This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.Here is a sample of this item:Greatbatch, Inc. Reports 2009 Third Quarter Results 2009-11-05 18:25 ET - News Release CLARENCE, N.Y. -- (Business Wire)
Greatbatch, Inc. (NYSE:GB), today announced results for its third
quarter ended October 2, 2009:
- CRM/Neuromodulation revenue growth of 5%
- Orthopaedic and Electrochem revenue negatively impacted by market
slowdown
- GAAP operating results include impact of $34.5 million Electrochem
litigation charge
- Cash flows from operations of $29 million
- Consolidation initiatives remain on track
- Annual operating margin guidance maintained on reduced full year
revenue expectations
|
(Dollars in thousands, except share data)
|
| 2009 3rd Qtr. |
| 2008 3rd Qtr. |
| % Change |
| 2009 2nd Qtr. |
| % Change | |
Revenue
|
|
$
|
121,470
| |
|
$
|
136,242
| |
|
-11
|
%
|
|
$
|
134,725
| |
|
-10
|
%
| |
GAAP Operating Income (Loss)
| |
$
|
(23,933
|
)
| |
$
|
15,714
| | |
NA
| |
$
|
12,469
| | |
NA
| |
GAAP Operating Income (Loss) as % of Sales*
| | |
-19.7
|
%
| | |
11.5
|
%
| | | | |
9.3
|
%
| | | |
Adjusted Operating Income*
| |
$
|
13,646
| | |
$
|
19,279
| | |
-29
|
%
| |
$
|
14,893
| | |
-8
|
%
| |
Adjusted Operating Income as % of Sales
| | |
11.2
|
%
| | |
14.2
|
%
| | | | |
11.1
|
%
| | | |
GAAP Diluted EPS
| |
$
|
(0.90
|
)
| |
$
|
0.28
| | |
NA
| |
$
|
0.28
| | |
NA
| |
Adjusted Diluted EPS*
| |
$
|
0.32
| | |
$
|
0.44
| | |
-27
|
%
| |
$
|
0.40
| | |
-20
|
%
|
The remainder is available to Stockwatch subscribers. If you would like to give the Stockwatch system a try,
click here for a free 30 day trial subscription. |